Denver, CO, May 30, 2005 --(PR.com
)-- Ed Wood, CEO of Summit Roundtable in Lakewood, was named Chairperson of the Board of Directors for the Colorado BioScience Association (CBSA) at its 2005 Annual All-Member Meeting held at Denverís National Jewish Medical & Research Center in April. The announcement is made by Denise Brown, CBSA Executive Director, who says Wood assumes chairperson responsibilities from Ralph (Chris) Christoffersen, General Partner, Morgenthaler Ventures, Boulder office (www.morgenthaler.com/ventures).
Vice Chairperson of the CBSA board is Jack Wheeler, CEO of Microphage, Inc. (www.micro-phage.com), headquartered in Longmont. In other action, four new board members were appointed, and nine existing board members reappointed, to three-year terms.
The CBSA board is comprised of members from traditional biotechnology companies (20%), traditional medical device companies (20%), research organizations (10%), service providers (10%) and emerging companies (10%). The remaining 30% is based on need and opportunity according to association bylaws. New CBSA board members receiving three-year appointments include: Tom Miller, President, Emerging Medical Technologies; Tom Cycyota, President & CEO, AlloSource (www.allosource.org); Tom Roach, CPA, Ernst & Young (www.ey.com); and Maggie Chamberlin Holben, APR, Absolutely Public Relations (www.absolutelypr.com).
Those CBSA board members reappointed to three-year terms are: William Freytag, President & CEO, Myogen (www.myogen.com); Rick Jory, President & CEO, Sandhill Scientific (www.sandhillsci.com); Lynn Taussig, President & CEO, National Jewish Medical & Research Center (www.njc.org); John Eckstein, Director, Fairfield and Woods, P.C. (www.fwlaw.com); Brent Hinkston, Area Executive, IBM Life Sciences (www.ibm.com/industries/healthcare); Steve Onody, CEO, Onody Associates (www.onodyassoc.com); Clay Anselmo, President & COO, Reglera (www.reglera.com); Jack Wheeler, CEO, MicorPhage (www.micro-phage.com); and Paul Ray, President & CEO, Nervonix (www.nervonix.com).
About Ed Wood, CBSA Chairperson
Wood is the Executive Chairman of Mission Medical, Inc., a Fremont, CA, company that is automating the collection process for whole blood. Previously, he was the founding CEO of COBE BCT, Inc., a Gambro company specializing in therapeutic apheresis and apheresis platelet collection for blood centers. During his tenure at COBE BCT, Wood led the companyís growth to exceed a worldwide market share of over 50% in the therapeutic apheresis and 35% in the blood center markets, respectively. After departing COBE BCT, he became the first non-blood banker to be elected to the board of directors of the American Association of Blood Banks. He is currently the CEO of Summit Roundtable, a Colorado consulting firm that coaches small medical device companies to achieve market and financial success. He serves on the boards of Engineering Research Associates, Inc; MonoGen Inc. (http://www.monogen.com); and CytoLogic, Inc. He received his BS degree in chemistry from Harvey Mudd College, and his MBA from the University of Colorado. You can learn more about Woodís consulting firm at http://www.summitroundtable.com.
About Colorado BioScience Association
Colorado BioScience Association is a not-for-profit corporation providing services and support for Coloradoís growing biosciences industry. Colorado is carrying out an aggressive plan to grow the stateís bioscience industry into one of the countryís premier bioscience clusters. CBSA currently enjoys the support of 304 member organizations representing both bioscience companies and companies providing key services to the bioscience industry and research institutions in Colorado. The associationís main office is located in the Advance Colorado Center, 1625 Broadway, Suite 950, in Denver, plus satellite offices are maintained in the Fitzsimons Bioscience Park and at the Fort Collins Technology Incubator. A Colorado Springs satellite office is planned for the future. You can learn more about CBSA at www.cobioscience.com
Denise Brown, Executive Director, Colorado BioScience Association, 303.592.4073, E-mail: email@example.com
Maggie Chamberlin Holben, APR, Absolutely Public Relations, 303.984.9801 or 303.669.3558, E-mail: firstname.lastname@example.org